Skip to main content
Official EU label nameGlossary entry 17055

MYRICITRIN

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence
Markets checked
13
Markets with evidence
0
Evidence gaps
13
Resolved identifiers
1

Resolved substance identity

CAS:17912-87-7
Ingredient index records:
MYRICITRIN
Cosmetic functions: ANTIOXIDANT, SKIN PROTECTING

4H-1-Benzopyran-4-one, 3-[(6-deoxy-.alpha.-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-

1 matched or reported name
MYRICITRIN

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name MYRICITRIN.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Chemical identity and properties

PubChem 2D chemical structure for CAS 17912-87-7
CAS 17912-87-7PubChem CID 5281673

Myricitrin

Myricitrin is a glycosyloxyflavone that consists of myricetin attached to a alpha-L-rhamnopyranosyl residue at position 3 via a glycosidic linkage. Isolated from Myrica cerifera, it exhibits anti-allergic activity. It has a role as an EC 2.7.11.13 (protein kinase C) inhibitor, an anti-allergic agent, an EC 1.14.13.39 (nitric oxide synthase) inhibitor and a plant metabolite. It is a pentahydroxyflavone, an alpha-L-rhamnoside, a glycosyloxyflavone and a monosaccharide derivative. It is functionally related to a myricetin. It is a conjugate acid of a myricitrin(1-). — ChEBI

IUPAC name
5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
Molecular formula
C21H20O12
Molecular weight
464.4 g/mol
Exact mass
464.09547607 Da
XLogP3
0.5
Topological polar surface area
207.0 Ų
Hydrogen-bond donors
8
Hydrogen-bond acceptors
12
Covalent units
1
Defined stereocentres
5

Also known as

MyricitrosideMyricitrineMyricetin 3-O-rhamnosideMyricetin 3-O-alpha-L-rhamnopyranoside5Z0ZO61WPJFEMA NO. 4491CHEBI:70082NSC-19803
16 more reported names
5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside5,7-dihydroxy-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-oneRefChem:1603953,3',4',5,5',7-Hexahydroxyflavone 3-Rhamnoside241-856-7MyricetrinMyricetol 3-rhamnosideMyricetin 3-O-alpha-L-rhamnoside5,7-dihydroxy-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-benzopyran-4-one5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one3,3',4',5,5',7-Hexahydroxyflavone, 3-rhamnoside3-[(2S,3R,4R,5R,6S)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5,7-bis(oxidanyl)-2-[3,4,5-tris(oxidanyl)phenyl]chromen-4-one4H-1-Benzopyran-4-one, 3-[(6-deoxy-.alpha.-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-Flavone,3,3',4',5,5',7-hexahydroxy-,3-rhamnosideUNII-5Z0ZO61WPJ
External database identifiers

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Take this record further

Screen in a formulaOpen standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision